Jeff Yass’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-4,800
Closed -$218K 13805
2021
Q3
$218K Sell
4,800
-5,800
-55% -$266K ﹤0.01% 11300
2021
Q2
$519K Sell
10,600
-800
-7% -$38.3K ﹤0.01% 9487
2021
Q1
$573K Buy
+11,400
New +$631K ﹤0.01% 9172
2020
Q3
Sell
-5,100
Closed -$213K 11069
2020
Q2
$213K Sell
5,100
-2,500
-33% -$98.6K ﹤0.01% 8929
2020
Q1
$241K Buy
+7,600
New +$291K ﹤0.01% 8369
2019
Q3
Sell
-5,900
Closed -$213K 10754
2019
Q2
$213K Sell
5,900
-7,900
-57% -$272K ﹤0.01% 9011
2019
Q1
$499K Buy
+13,800
New +$461K ﹤0.01% 6283
2018
Q4
Sell
-8,900
Closed -$350K 9839
2018
Q3
$350K Sell
8,900
-1,100
-11% -$41.7K ﹤0.01% 7176
2018
Q2
$373K Sell
10,000
-8,800
-47% -$319K ﹤0.01% 7417
2018
Q1
$644K Buy
18,800
+400
+2% +$14K ﹤0.01% 6142
2017
Q4
$603K Buy
18,400
+1,400
+8% +$43.8K ﹤0.01% 6274
2017
Q3
$530K Sell
17,000
-2,900
-15% -$85.1K ﹤0.01% 6411
2017
Q2
$554K Buy
19,900
+8,800
+79% +$229K ﹤0.01% 6455
2017
Q1
$286K Buy
+11,100
New +$276K ﹤0.01% 7414
2016
Q4
Sell
-18,200
Closed -$475K 10075
2016
Q3
$475K Sell
18,200
-11,100
-38% -$277K ﹤0.01% 6149
2016
Q2
$663K Buy
+29,300
New +$696K ﹤0.01% 5635
2016
Q1
Sell
-16,300
Closed -$518K 9575
2015
Q4
$518K Buy
16,300
+2,400
+17% +$73.6K ﹤0.01% 6699
2015
Q3
$388K Buy
+13,900
New +$485K ﹤0.01% 7602

Other funds holding SBIO

Jeff Yass's SBIO Position: Q2 2026 in Review

Jeff Yass sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q2 2026, closing a stake of 60,686 shares — an estimated $3.18M sold.

Jeff Yass first reported a position in SBIO in Q2 2015 and held it in 33 quarters. The position peaked at $3.18M in Q1 2026. 64 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.

  • Jeff Yass reported no remaining ALPS Medical Breakthroughs ETF position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 60,686 ALPS Medical Breakthroughs ETF shares in Q2 2026, an estimated $3.18M.
  • Jeff Yass first reported a position in ALPS Medical Breakthroughs ETF in Q2 2015 and held it in 33 quarters.
  • Jeff Yass's ALPS Medical Breakthroughs ETF position peaked at $3.18M in Q1 2026.
  • 64 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.